Skip to main content

Diseases with Occluded Sweat Ducts other than Eczema (Tinea Pedis, Axillary Granular Parakeratosis, and Seborrheic Dermatitis)

  • Chapter
  • First Online:
The Etiology of Atopic Dermatitis
  • 1075 Accesses

Abstract

Tinea pedis, “fungus of the foot,” involves marked toeweb scaling, a “moccasin” pattern of scaling on the soles, and maceration. Dermatophytes including Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum are responsible. T. rubrum is ubiquitous, especially in locker rooms and showers (causing “athlete’s foot”). The same phenomenon is occurring in tinea pedis as in eczema. The difference is that in tinea pedis the fungus disrupts the stratum corneum and plays the role that genetic abnormalities play in eczema. Axillary granular parakeratosis, a rare disease with an unknown cause, presents clinically with a pruritic, hyperpigmented or dull red hyperkeratotic plaque in the axilla. In our examination of multiple sections of a specimen from axillary granular parakeratosis, we found periodic acid–Schiff positive occluded sweat ducts in the upper epidermis and proximal stratum corneum. We believe the occlusions arise from staphylococcal biofilms similar to those seen in miliaria, and the granules play the role of genetic abnormalities in eczema. In seborrheic dermatitis, biofilm-producing staphylococci and occluded sweat ducts form the environmental “hit” of the double-hit phenomenon and yeasts play the role of the genetic abnormalities in eczema. Management of seborrheic dermatitis usually involves bland shampoo and infrequent use of soap. The response is similar to eczema because it truly is eczema. “Cradle cap” is similar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sobera JO, Elewski BE. Fungal diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. Barcelona: Mosby Elsevier; 2008. p. 1135–63. An excellent synopsis of tinea pedis, its fungal etiologies, clinical characteristics, and treatment.

    Google Scholar 

  2. Tong MM, Altman PM, Barnetson RS. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol. 1992;33(3):145–9. This study of 104 patients showed that tea tree oil cream (10 % w/w) has the same clinical efficacy as tolnaftate 1 % at reducing scaling, inflammation, itching, and burning of tinea pedis. However, tea tree oil is just as effective as placebo at converting to negative cultures; tolnaftate is superior to both tea tree oil and placebo in this regard.

    Article  CAS  PubMed  Google Scholar 

  3. Jancin B. Topical antifungals: newer agents work faster but not better than older ones. Intern Med News. 2007;40:24. http://www.internalmedicinenews.com/index.php?id=495&tx_ttnews%5Btt_news%5D=13190&cHash=225ea926c9. Reports on a presentation by Kress at the Hawaii Dermatology Seminar (Maui, March 3–9, 2007) indicating very low mycological cure rates for the “azole” topical antifungals. Clinical cure rates were markedly higher

  4. Jones HE. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol. 1993;28(5 Pt 1):S12–8.

    Article  CAS  PubMed  Google Scholar 

  5. Almeida SR. Immunology of dermatophytosis. Mycopathologia. 2008;166(5–6):277–83. The papers by Jones and Almeida nicely summarize the phenomenon whereby individuals who mount a delayed-type hypersensitivity reaction to Trichophyton clear the infection, whereas those who mount a high immediate hypersensitivity but low or waning delayed-type hypersensitivity cannot clear the infection and develop tinea pedis. Interestingly, while the latter patients constitute the 10–20 % of the general population prone to reinfection with dermatophytes, they have a normal response to other infectious agents.

    Article  PubMed  Google Scholar 

  6. Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771–88. Lodén explains how emollients and moisturizing creams improve barrier function in skin disorders such as atopic dermatitis, psoriasis, ichthyosis, and contact dermatitis. Not all emollients and moisturizers are created equal, but ceramide-containing topicals have been shown to improve barrier function in atopic dermatitis. Previous to this book, no research has been published regarding the use of topical ceramides in tinea pedis.

    Article  PubMed  Google Scholar 

  7. O’Brien JP. The pathogenesis of miliaria. Arch Dermatol. 1962;86:267–70. A superb explanation of the pathogenesis of miliaria. O’Brien showed that the application of lanolin to miliaria unblocked sweat ducts, causing the resumption of sweat production.

    Article  PubMed  Google Scholar 

  8. Scheinfeld NS, Mones J. Granular parakeratosis: pathologic and clinical correlation of 18 cases of granular parakeratosis. J Am Acad Dermatol. 2005;52(5):863–7. The authors discuss 18 cases in which they found a very low incidence (0.05 %) of this disease in their specimens. They did discern all the ordinary findings, including the myriad granules in the stratum granulosum along with the hyperkeratosis, irregular acanthosis, and focal spongiosis.

    Article  PubMed  Google Scholar 

  9. Burford C. Granular parakeratosis of multiple intertriginous areas. Australas J Dermatol. 2008;49(1):35–8. A patient had an eruption of granular parakeratosis in the inframammary and inguinal regions along with transient involvement of the axillae. The granules were present in the stratum and the hyperkeratosis acanthosis was somewhat more variable.

    Article  PubMed  Google Scholar 

  10. Chamberlain AJ, Tam MM. Intertriginous granular parakeratosis responsive to potent topical corticosteroids. Clin Exp Dermatol. 2003;28(1):50–2. Three patients, with characteristic disease, had rapid recovery of their lesions with the above treatment.

    Article  CAS  PubMed  Google Scholar 

  11. Hay RJ. Malassezia, dandruff and seborrhoeic dermatitis: an overview. Br J Dermatol. 2011;165 Suppl 2:2–8. Hay reviews these conditions and the possible roles of Malassezia organisms in their pathogenesis. For example, oleic acid, produced by Malassezia globosa, disrupts the stratum corneum and is responsible for the desquamation/scaling evident in seborrheic dermatitis.

    Article  PubMed  Google Scholar 

  12. Hoopes HI, Noro MG, Longo ML, Faller R. Bilayer structure and lipid dynamics in a model stratum corneum with oleic acid. J Phys Chem B. 2011;115(12):3164–71. It is well understood that the stratum corneum serves as a barrier against the invasion of microorganisms and other molecules from the environment. Any change in the stratum corneum may compromise its barrier function. Based on this understanding, in this study, a model of the stratum corneum was created and exposed to oleic acid to observe the effect of the acid on the density and thickness of the stratum corneum. The effects of increasing concentrations of oleic acid were observed at two different temperatures: 300 K, which is representative of normal skin, and 340 K, which provides increased dynamic effects. Density was decreased with increased concentration of oleic acid at both temperatures, but the effect was greater with the higher temperature.

    Article  CAS  PubMed  Google Scholar 

  13. Hoet PHM, Brüske-Hohlfeld I, Salata OV. Nanoparticles – known and unknown health risks. J Nanobiotechnology. 2004;2:12. doi:10.1186/1477-3155-2-12.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Sulzberger MB, Hermann F, Zak FG. Studies of sweating. I Preliminary report with particular emphasis on a sweat retention syndrome. J Invest Dermatol. 1947;9(5):221–42. Dr. Sulzberger and his colleagues observed the plugging of the sweat gland orifices and considered that it played an important role in the pathogenesis of atopic dermatitis, ichthyosis, atypical seborrheic dermatitis, and patchy prickly heat. They exposed patients, presumably with these diseases, to transient heat and found that the patients had typical clinical and histologic findings. Clinically, they found that patients immediately developed pruritus and malaise and had decreased sweating as evidenced by starch iodine tests and increased pH on the skin surface. Subjects also developed new or more pronounced papulovesicles that had the low pH of sweat. On pathology, numerous sweat glands showed plugging. Biopsies after heat exposure showed increased vesicle formation and exocytosis.

    Article  CAS  PubMed  Google Scholar 

  15. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics. 1982;69(1):81–3. In 1982, Allen et al. reported that selenium sulfide has sporicidal properties. We divided children into two groups, one treated with griseofulvin and selenium sulfide shampoo and the other with griseofulvin only. After 2 and 8 weeks of treatment, the group treated with selenium sulfide had negative fungal cultures while the group treated with griseofulvin alone had positive fungal cultures. Selenium was also shown to inhibit Trichophyton tonsurans growth on cultures not only at 2.5 % solution, but also at a dilution of 1:10.

    CAS  PubMed  Google Scholar 

  16. Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387–96. These authors review the clinical variants, presentations, and topical treatments of seborrheic dermatitis in various patient populations (patients with HIV infection, infants, etc.).

    Article  CAS  PubMed  Google Scholar 

  17. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13–26. The authors discuss the different presentation and severity of seborrheic dermatitis in patients with HIV infection, infants, and patients with neurological diseases. They also discuss the various treatment options available including the use of ketoconazole in treating seborrheic dermatitis in AIDS patients.

    Article  CAS  PubMed  Google Scholar 

  18. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32–8. This author discusses the topical treatment options available for seborrheic dermatitis, including antifungals, calcineurin inhibitors, and topical corticosteroids. Scalp seborrheic dermatitis is associated with greater severity of pruritus compared with seborrheic dermatitis elsewhere.

    PubMed Central  PubMed  Google Scholar 

  19. Quinn CR. Seborrheic dermatitis. In: Kelly AP, Taylor SC, editors. Dermatology for skin of color. New York: McGraw-Hill; 2009. p. 241–4. This book chapter discusses the various presentations of seborrheic dermatitis in skin of color. Infantile seborrheic dermatitis, also known as “cradle cap,” can be treated with several different oils in addition to antifungual shampoos. According to the authors, olive oil or mineral oil helps to loosen the scale of infantile seborrheic dermatitis from the scalp.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Allen, H.B. (2015). Diseases with Occluded Sweat Ducts other than Eczema (Tinea Pedis, Axillary Granular Parakeratosis, and Seborrheic Dermatitis). In: The Etiology of Atopic Dermatitis. Springer, London. https://doi.org/10.1007/978-1-4471-6545-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6545-3_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6544-6

  • Online ISBN: 978-1-4471-6545-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics